• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

C5G:GR

12.200 EUR 0.0000.00%

As of 02:17:03 ET on 04/17/2014.

Snapshot for Orexo AB (C5G)

Open: 12.200 Day's Range: 12.200 - 12.200 Volume: 0
Previous Close: 12.200 52wk Range: 5.636 - 20.280 1-Yr Rtn: +115.89%

Stock Chart for C5G

No chart data available.
  • C5G:GR 12.200
  • 1D
  • 1M
  • 1Y
12.200
Interactive C5G Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for C5G

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 46.5840
Relative P/E vs. DAX -
Earnings Per Share (SEK) (ttm) -
Est. EPS (SEK) (12/2014) 2.3880
Est. PEG Ratio -
Market Cap (M EUR) 401.85
Shares Outstanding (M) 32.94
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/25/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for C5G

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for C5G

Orexo AB is a product oriented drug delivery company that develops new pharmaceuticals by further develop existing products. The Company specializes in drugs in tablet form especially sublingual pills and often works together with scientists and other corporations. Orexo sells internationally.

Martin NicklassonChairmanNikolaj SorensenChief Executive Officer
Henrik JuuelExec VP/CFO
More Company Profile & Key Executives for C5G

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil